TMCnet News
Don't Wait!! Sign Up Now!! JEDM,CIST,IWEB,NXTH,GHLV,NNVC(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (PINKSHEETS: JEDM) Jedi Mind, Inc., (PINKSHEETS: CIST) Cityside Tickets Inc., (OTCBB: IWEB) IceWEB, Inc., (OTCBB: NXTH) NXT Nutritionals Holdings, Inc., (OTCBB: GHLV) Global Health Ventures, Inc., (OTCBB: NNVC) NanoViricides, Inc. www.StockMarketingInc.com To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com email us!! [email protected] or call 1-866-583-8960 ------------------------------------------------------------------------------------------------------------------------------------------------------------ (PINKSHEETS: JEDM - Jedi Mind, Inc.) LATEST NEWS!! Jedi Mind To Be Featured Nationwide on Fox Business Network CARDIFF, Calif., Feb 24, 2010 -- Jedi Mind, Inc. (Pink Sheets: JEDM) has received confirmation that The Company's featured segment of "Inside Business," hosted by Senator Fred Thompson, will be aired Nationwide on Fox Business Network March 27th at 4 pm EST. The feature will be aired throughout the entire country and is one of several planned airings that will reach approximately 90 million viewers over the next 60 days. Jedi Mind has also received confirmation of the featured segment to be aired in the Phoenix, AZ market on KAZTV March 6th, 13th, 20th and 27th. The Company will post these dates and times, as well as additional airings, on their website shortly. The Company believes this Nationwide exposure of our revolutionary technology will expose our applications and stock to millions of individuals for the first time who are not aware that this technology even exists. About Jedi Mind, Inc. Jedi Mind, Inc. develops software for thought controlled technologies, allowing the user to interact with the computer and other machines through the power of the mind. The technology involves the use of a wireless headset, developed by our strategic partner, which detects brainwaves on both the conscious and non-conscious level. This revolutionary neural processing technology makes it possible for computers to interact directly with the human brain. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (PINKSHEETS: CIST - Cityside Tickets Inc.) LATEST NEWS!! CitySide Tickets, Inc. Featured in Boston Herald BOSTON, Feb 25, 2010 -- CitySide Tickets, Inc. (PINKSHEETS: CIST), which owns and operates www.CitySidetickets.com, a nationwide event ticket purchasing venue that caters to a diverse selection of popular theater, music, and sporting events, is pleased to announce that on Monday, February 22, 2010, the company was featured in an exclusive article featuring its national television advertising campaign. As previously announced, over the next three weeks CitySide Tickets will run multiple versions of a 30 second commercial more than 500 times on national cable news channels including Bloomberg, CNBC, CNN, Fox News and MSNBC. The commercials are designed to yield hundreds of telephone calls per day from people interested in using CitySide Tickets to buy and sell their tickets to concerts, sports contests, theatrical productions and other events. Company CEO Michael DeAmicis stated, "CitySide Tickets, Inc. is just getting the ball rolling. We are very excited about the next couple of months as we expand our presence into other markets across the nation. I'm confident that we will make a big impact on the ticket selling industry as we move forward with our strategic business plan." About CitySide Tickets, Inc. CitySide Tickets, Inc. is positioning itself to become a major player in the event ticket market. CitySide offers a diverse range of tickets, including concert tickets, theater tickets, and sports tickets for sale through their website at www.CitySidetickets.com. In addition, visitors to the company's website can use the site to sell tickets they have available. CitySide Tickets also offers tickets to Major League Baseball, NBA Basketball, NFL Football, and NHL Hockey events. They also offer Monster Jam tickets, National Finals Rodeo tickets, Ultimate Fighting Championship tickets, U.S. Open Tennis Championship tickets, and WWE-World Wrestling Entertainment tickets. Currently, CitySide Tickets is offering concert tickets for acts such as Taylor Swift, Bon Jovi, Lady Gaga, and Elton John & Billy Joel, to name a few. For Theatre tickets, the company is offering tickets for Wicked, The Jersey Boys, South Pacific, and Phantom of the Opera, among others. Racing events offered include tickets to the Daytona 500 at Daytona International Speedway as well as the Atlanta Motor Speedway, Darlington Raceway, Indianapolis Motor Speedway, Michigan International Speedway, Pocono Raceway, and Watkins Glen International. For more information, please visit the Company's website at: www.CitySidetickets.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: IWEB - IceWEB, Inc.) LATEST NEWS!! VideoBank Selects IceWEB Storage for Its Customer Deployments Initial Order for 62 Terabytes to be Delivered this Quarter STERLING, Va., Feb 23, 2010 -- IceWEB, Inc. (OTC Bulletin Board: IWEB), , a leading provider of building blocks for cloud storage networks and purpose built appliances, announced today that it has been chosen by VideoBank, to deliver storage for a government and commercial solution deployments. "The performance and features of the IceWEB platform made the decision easy. IceWEB's thin provisioning and storage pooling make it easy for our customers to increase storage capacity, an important feature for our customers," said Lou Siracusano, CEO for VideoBank. "IceWEB's experience and excellent reputation providing storage building blocks for leading software companies solidified our decision." "We are honored to be chosen by VideoBank, a leader in providing video platforms for commercial and government programs," said Tim McNamee, Director of Business Development for IceWEB. "With video content growing at more than 30% annually, the video market is an important vertical market for our growth." About VideoBank For more than a decade, VideoBank has revolutionized the ways in which educational institutions, medical facilities, government organizations, entertainment companies and the U.S. military have archived, managed, and distributed their products and services worldwide. More importantly, our systems have transformed the way the men and women of our armed forces gather and utilize intelligence both at home and abroad. At VideoBank we make it our responsibility to stay on the cutting edge of technology, which helps allow business leaders, doctors, teachers, government officials and soldiers to concentrate their energies where they truly belong -- on serving their local and global communities. About IceWEB, Inc. Headquartered just outside of Washington, D.C., IceWEB manufactures and markets purpose built appliances, network and cloud storage solutions and delivers on-line cloud computing application services. Its customer base includes U.S. government agencies, enterprise companies, and small to medium sized businesses (SMB). For more information, please visit www.IceWEB.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: NXTH - NXT Nutritionals Holdings, Inc.) LATEST NEWS!! NXT Nutritionals Signs Eddie George, Heisman Trophy Winner and Former NFL Player, to Promote National Rollout of SUSTA(TM) Natural Sweetener and Healthy Dairy(R) Yogurt Smoothies HOLYOKE, Mass., Feb 23, 2010 -- NXT Nutritionals Holdings, Inc. (OTCBB: NXTH), developer and marketer of SUSTA(TM) Natural Sweetener, the great tasting, all-natural, healthier sweetener, announced today that former NFL All-Pro player, and Heisman Trophy winner, Eddie George has agreed to promote SUSTA(TM) Natural Sweetener and Healthy Diary(R) Yogurt Smoothies in its nationwide expansion. To raise awareness of the SUSTA brand when SUSTA arrives in Kroger stores this month in the Columbus, Ohio, area, Eddie George will be making in-store appearances, local television and radio interviews. George has been an advocate for improving health and wellness among Americans. For the past three years, he and his wife Taj have teamed up with Dr. Oz on "The Dr. Oz Show." Together they coached and motivated the moms throughout the 2009 NFL season as part of a national viewer challenge to inspire moms and families everywhere to improve their health. The winner of the challenge was announced on the website of the "The Dr. Oz Show." "Being an entrepreneur and businessman," George said, "I appreciate the dedication that Mike and his team at NXT Nutritionals have in building a product line and brand presence in a competitive marketplace." "The great tasting all-natural SUSTA is unique in that there is no other sweetener that has all the health benefits that SUSTA provides. I am a true supporter of SUSTA and I intend to do my part to inform consumers about this amazing sweetener," added George. Michael McCarthy, president and CEO of NXT Nutritionals, said, "Eddie is committing his time and energy to motivate Americans to live healthier lifestyles. His willingness to work on this issue is why we asked him to join us in our crusade. I am thrilled to have him on the team." "We hope Eddie can help us bring SUSTA and Healthy Dairy to the attention of those health activists, such as Dr. Oz and the NFL organization, that are already leading the country's battle against diabetes and obesity," said McCarthy. In 2006, George was named a spokesperson for Tennessee's GetFitTN program by Governor Phil Bredesen. GetFitTN is a statewide awareness program to address the rising epidemic of Type 2 diabetes and risk factors that lead to diabetes, such as obesity. This initiative is aimed at educating both adults and children that Type 2 diabetes can be delayed or even prevented with modest lifestyle changes such as increasing physical activity and a healthier diet. George won the Heisman Trophy during his senior year as a running back at Ohio State in 1995. In 1996, he began his professional career with the Houston Oilers, now the Tennessee Titans, as starting tailback, winning several NFL Rookie of the Year awards and virtually owning every franchise rushing record. George led the AFC Champion Titans to Super Bowl XXXIV in 2000, retiring from the NFL before the 2005 season. He made the Pro Bowl four consecutive years. George recently earned an MBA in the Executive MBA program of the Kellogg School of Management, Northwestern University. About NXT Nutritionals Holdings, Inc. Headquartered in Holyoke, MA, NXT Nutritionals Holdings, Inc., through its wholly owned subsidiary NXT Nutritionals, Inc., is a developer and marketer of a proprietary, patent-pending, all--natural, healthy sweetener sold under the brand name SUSTA(TM) and other food and beverage products. SUSTA(TM) Natural Sweetener, sold as a stand-alone product and the common ingredient for all of the Company's products, is an all natural, healthy sweetener that has minimal calories and low glycemic index. NXT Nutritionals has also developed a line of SUSTA(TM)-enhanced best-in-class, non-fat reduced-calorie yogurt smoothies that are marketed as Healthy Dairy(R) Yogurt Smoothies. For additional information, please visit NXT Nutritionals' corporate website: www.nxtnutritionals.com ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: GHLV - Global Health Ventures, Inc.) LATEST NEWS!! Global Health Ventures to Initiate Human Clinical Trials in Europe for X-Excite, Its Male Sexual Enhancement Drug VANCOUVER, BRITISH COLUMBIA, Feb 24, 2010 -- Global Health Ventures Inc. (OTCBB: GHLV), or the "Company", is pleased to announce that it has engaged Clinical Investigations Ltd. of United Kingdom to design and carry out the human clinical trials for X-Excite in Europe under the European Regulatory Guidelines (EMEA). The study is designed to compare three doses of X-Excite with the current oral formulation of sildenafil citrate (Viagra(R)) in a randomized open labeled study. The focus of the study will be to obtain Pharmacokinetics, bioavailability, and the efficacy of X-Excite in comparison with the existing Viagra(R) tablets. These trials which will be conducted in patients with erectile dysfunction shall set up the basis for a larger and more comprehensive trial in North America under the FDA guidelines. The Company shall make announcements on the patient's enrolment, and timeline for the results of these clinical trials. "We are very pleased that our product, X-Excite is now entering human clinical trials, a significant milestone in the development and progression of this drug. We now can move aggressively forward towards regulatory approval and eventual marketing of our drug, X-Excite," said Dr. Hassan Salari, Global Health President and CEO. About X-Excite X-Excite is a new formulation of an existing sexual enhancement drug, which is designed to rapidly enter the blood system, maximizing its efficacy and performance. The drug is developed to work sublingually, thus having a more rapid mode of action, and bypassing all the inconveniences and many side effects associated with other application routs. Life style products, such as Viagra(TM), Cialis(TM) and Levitra(TM), etc are highly lucrative (nearly $5 billion), products for pharmaceutical companies. This lucrative market will continue to grow for the foreseeable future. The arrival of our new drug (X-Excite) with its fewer side effects and the rapid mode of action meets and will exceed the markets needs. About Global Health Ventures The Company is a specialty pharma focused on the life style products. The Company is developing a new proprietary platform technology that delivers many approved drugs via the sublingual (under the tongue) route. This unique method delivers low dose drugs directly to the blood stream, bypassing all the side effects of digestive and liver system breakdowns, while maintaining product efficacy. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: NNVC - NanoViricides, Inc.) LATEST NEWS!! NanoViricides Files Quarterly Report WEST HAVEN, Conn., Feb 23, 2010 -- NanoViricides, Inc. (OTCBB: NNVC), has filed its quarterly report with the Securities and Exchange Commission yesterday in a timely fashion. The Company reports that it had approximately $4.03M in cash and $313,000 in prepaid expenses as of December 31, 2009, the end of the reporting quarter. The shareholder equity stood at approximately $4.35M. In comparison, the Company had approximately $1.69M in cash, $321,000 in prepaid expenses, and $2.48M in shareholder equity as of the financial year ended June 30, 2009. The Company spent approximately $630,000 in Research and Development expenses (R&D) and $297,000 in General and Administrative expenses (G&A) in the reported quarter, in comparison to approximately $427,000 for R&D and $217,000 for G&A for the quarter ended December 31, 2008, one year ago. The Company has no long term debt. The Company estimates that it currently has sufficient cash in hand to achieve the budgeted objectives through December 31, 2010. In addition, the Company also reported that it has completed the signing of an additional licensing agreement for nanoviricides(R) drug candidates against Dengue viruses, West Nile virus, Japanese Encephalitis virus, epidemic kerato-conjunctivitis (EKC) causing viruses, Ebola, and Marburg viruses, with TheraCour Pharma, Inc. The terms for the license are similar to the prior license and the up-front compensation portion was paid in terms of restricted, preferred stock which has no current market and is convertible into shares of common stock only in the event of a change of control of the Company. There was no cash paid to TheraCour for the additional license agreement. "We are now committed to developing a single broad-spectrum nanoviricide drug that attacks all four serotypes of dengue and their variants. We are also making progress in the development of a single broad-spectrum nanoviricide for many different viral infections of the external eye, including EKC and herpes keratitis," he said further, explaining the additional license agreement that, "the Market Sizes for these diseases are anticipated to be in the billions of dollars. We were negotiating a license agreement for these viruses with TheraCour for some time now, and we have been able to execute it on terms that are extremely favorable for our shareholders." "We continue to be frugal and productive in our operations. The strong shareholder equity and cash holdings should enable us to move onto a National Stock Exchange," said Eugene Seymour, MD, MPH, CEO of the Company, adding, "We have been preparing to apply for a listing on either NASDAQ or the American Stock Exchange (Amex)." About NanoViricides: NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide(R) class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. ------------------------------------------------------------------------------------------------------------------------------------------------------------ About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. ((Comments on this story may be sent to [email protected])) (c) 2010 M2 COMMUNICATIONS |